Back

What is the long term incidence and the natural history of infection of subcutaneous implantable cardioverter-defibrillators? Results from a nationwide cohort

1 September 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: The good, the bad, and the ugly of device therapy Device Complications and Lead Extraction ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jacques Mansourati

University Hospital of Brest, Brest (France)

6 More presentations in this session

Presentation thumbnail
Temporal trends in utilization of transvenous lead extraction among patients with cardiac implantable electrical device infection
Doctor K. Fukuzawa (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
A european survey of CIED infection management: identifying physician aptitude and assessing their evolution of knowledge over three years
Professor J. Weil (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Analysis on etiology and progression of CIED-related tricuspid valve regurgitation at medium-term follow-up: untangling the tricuspid valve with 3DTTE
Doctor F. Fiorentini (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
High mortality and low utilization of investigations and lead extraction in a real-world cohort of CIED patients with Staphylococcus aureus bacteraemia
Doctor J. Latter (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Outcomes of entrapped right ventricular pacing or defibrillator leads following transcatheter tricuspid valve replacement
Doctor G. Peigh (Chicago, US)
Abstract Slides

Access the full session

Session thumbnail
The good, the bad, and the ugly of device therapy

The Event

Event poster

ESC Congress 2025

1 September 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Anaesthesia strategies for subcutaneous implantable cardioverter-defibrillator implantation: results from the HONEST national registry
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy
thumbnail
Congress Presentation
Subcutaneous implantable defibrillator therapy in patients with brugada syndrome: data from a large multicentre registry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources